SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 195.65-1.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (26628)11/20/1998 3:49:00 AM
From: Cheryl Galt  Read Replies (1) of 32384
 
Maybe there will be some ONTAK sales by year end.
Because of the delay, I was worried about the capability of Marathon, but the 10Q says:

INVENTORIES

... Seragen responded to the issues set out in the Complete Review Letter in August 1998 and is awaiting final FDA action.

In preparation for the approval by the FDA, if received, Seragen has manufactured commercial quantities of ONTAK(TM) and in purchase accounting for the Merger the Company has capitalized approximately $1.5 million of work-in-process inventory as of September 30, 1998.

If the FDA does not approve the BLA, and ONTAK(TM) is not approved for commercial sale, any capitalized costs related to ONTAK(TM) will be expensed.
--- 1998 3Q - 11/16/98 - freeedgar.com ---

That makes me feel more comfortable.
Maybe when Ontak is finally approved, the "surprise" will give the stock a boost.

Regards,
Cheryl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext